Resultados de la búsqueda 591-600 of 17402 for monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... antibody) * Olaparib (a type of PARP inhibitor). Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young. Rochester, Minn. The aim of this ...

  2. Mayo Clinic Physician Update - July 2022

    Page 1.

  3. Mayo Clinic Ophthalmology Physician Update - August 2022

    Page 1.

  4. Gammapatía monoclonal de significado incierto - Médicos y departamentos - Mayo Clinic

    Los investigadores de Mayo Clinic acuñaron el término gammapatía monoclonal de significado incierto. Han estado estudiando el trastorno durante décadas. El ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  6. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID). Rochester, Minn., Jacksonville, Fla. The purpose of this ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... antibody) * Olaparib (a type of PARP inhibitor). Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young. Rochester, Minn. The aim of this ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... antibody) * Olaparib (a type of PARP inhibitor). Comparison Of In-Home Versus In-Clinic Administration Of Subcutaneous Nivolumab Through Cancer CARE ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...